Avanos Medical, Inc.
US ˙ NYSE ˙ US05350V1061

SecurityAVNS / Avanos Medical, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership10,344 shares
Latest Disclosed Value $ 144,919
Citigroup Inc ownership in AVNS / Avanos Medical, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 10,344 shares of Avanos Medical, Inc. (US:AVNS) valued at $144,919 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 15,798 shares of Avanos Medical, Inc.. This represents a change in shares of -34.52% during the quarter. The current value of the position is $258,600 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (AVNS) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AVNS / Avanos Medical, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F AVANOS MED COM 05350V106 10,344 -5,454 -34.52 145 -18.64 0.0000
2026-02-13 2025-12-31 13F AVANOS MED COM 05350V106 15,798 -723 -4.38 177 -6.84 0.0001
2025-11-10 2025-09-30 13F AVANOS MED COM 05350V106 16,521 -26,256 -61.38 191 -63.67 0.0001
2025-08-11 2025-06-30 13F AVANOS MED COM 05350V106 42,777 -25,391 -37.25 524 -46.41 0.0003
2025-05-12 2025-03-31 13F AVANOS MED COM 05350V106 68,168 2,526 3.85 977 -6.60 0.0005
2025-02-12 2024-12-31 13F AVANOS MED COM 05350V106 65,642 6,447 10.89 1,045 -26.51 0.0006
2024-11-12 2024-09-30 13F AVANOS MED COM 05350V106 59,195 22,367 60.73 1,422 94.00 0.0008
2024-08-12 2024-06-30 13F AVANOS MED COM 05350V106 36,828 3,328 9.93 734 10.06 0.0005
2024-05-10 2024-03-31 13F AVANOS MED COM 05350V106 33,500 4,897 17.12 667 3.90 0.0004
2024-02-09 2023-12-31 13F AVANOS MED COM 05350V106 28,603 10,736 60.09 642 77.56 0.0005
2023-12-06 2023-09-30 13F/A-1 AVANOS MED COM 05350V106 17,867 -20,360 -53.26 361 -63.05 0.0003
2023-11-09 2023-09-30 13F AVANOS MED COM 05350V106 17,867 -20,360 361 0.0003
2023-08-10 2023-06-30 13F AVANOS MED COM 05350V106 38,227 12,308 47.49 977 26.88 0.0006
2023-05-11 2023-03-31 13F AVANOS MED COM 05350V106 25,919 -5,963 -18.70 771 -10.67 0.0005
2023-02-09 2022-12-31 13F AVANOS MED COM 05350V106 31,882 9,409 41.87 863 76.28 0.0007
2022-11-10 2022-09-30 13F AVANOS MED COM 05350V106 22,473 915 4.24 489 -16.98 0.0003
2022-08-10 2022-06-30 13F AVANOS MED COM 05350V106 21,558 -20,209 -48.39 589 -57.90 0.0004
2022-05-12 2022-03-31 13F AVANOS MED COM 05350V106 41,767 4,573 12.29 1,399 8.53 0.0009
2022-02-10 2021-12-31 13F AVANOS MED COM 05350V106 37,194 11,132 42.71 1,289 58.55 0.0007
2021-11-10 2021-09-30 13F AVANOS MED COM 05350V106 26,062 -932 -3.45 813 -17.13 0.0005
2021-08-10 2021-06-30 13F AVANOS MED COM 05350V106 26,994 22,352 481.52 981 383.25 0.0006
2021-05-13 2021-03-31 13F AVANOS MED COM 05350V106 4,642 -6,774 -59.34 203 -61.19 0.0001
2021-02-11 2020-12-31 13F AVANOS MED COM 05350V106 11,416 7,487 190.56 523 302.31 0.0003
2020-11-12 2020-09-30 13F AVANOS MED COM 05350V106 3,929 -12,959 -76.73 130 -73.79 0.0001
2020-08-12 2020-06-30 13F AVANOS MED COM 05350V106 16,888 1,407 9.09 496 18.94 0.0004
2020-05-12 2020-03-31 13F AVANOS MED COM 05350V106 15,481 4,582 42.04 417 13.62 0.0004
2020-02-12 2019-12-31 13F AVANOS MED COM 05350V106 10,899 7,364 208.32 367 178.03 0.0003
2019-11-08 2019-09-30 13F AVANOS MED COM 05350V106 3,535 -4,856 -57.87 132 -63.93 0.0001
2019-08-12 2019-06-30 13F AVANOS MED COM 05350V106 8,391 5,356 176.47 366 183.72 0.0003
2019-05-13 2019-03-31 13F AVANOS MED COM 05350V106 3,035 -15,322 -83.47 129 -84.31 0.0001
2019-02-12 2018-12-31 13F AVANOS MED COM 05350V106 18,357 5,733 45.41 822 -4.97 0.0008
2018-11-13 2018-09-30 13F AVANOS MED COM 05350V106 12,624 2,151 20.54 865 76.17 0.0008
2018-08-10 2018-06-30 13F HALYARD HEALTH COM 40650V100 10,473 -33,338 -76.10 491 -75.67 0.0005
2018-05-11 2018-03-31 13F HALYARD HEALTH COM 40650V100 43,811 -39,778 -47.59 2,018 -47.73 0.0017
2018-02-12 2017-12-31 13F HALYARD HEALTH COM 40650V100 83,589 -2,077 -2.42 3,861 0.10 0.0031
2017-11-13 2017-09-30 13F HALYARD HEALTH COM 40650V100 85,666 14,100 19.70 3,857 37.21 0.0032
2017-08-11 2017-06-30 13F HALYARD HEALTH COM 40650V100 71,566 59,036 471.16 2,811 489.31 0.0025
2017-05-12 2017-03-31 13F HALYARD HEALTH COM 40650V100 12,530 -51,592 -80.46 477 -79.88 0.0004
2017-02-10 2016-12-31 13F HALYARD HEALTH COM 40650V100 64,122 38,344 148.75 2,371 165.21 0.0021
2016-11-10 2016-09-30 13F HALYARD HEALTH COM 40650V100 25,778 11,243 77.35 894 89.41 0.0008
2016-08-12 2016-06-30 13F HALYARD HEALTH COM 40650V100 14,535 -28,685 -66.37 472 -61.94 0.0005
2016-05-13 2016-03-31 13F HALYARD HEALTH COM 40650V100 43,220 19,568 82.73 1,240 56.96 0.0014
2016-02-12 2015-12-31 13F HALYARD HEALTH COM 40650V100 23,652 12,504 112.16 790 149.21 0.0008
2015-11-13 2015-09-30 13F HALYARD HEALTH COM 40650V100 11,148 -11,158 -50.02 317 -64.93 0.0003
2015-08-13 2015-06-30 13F HALYARD HEALTH COM 40650V100 22,306 -820 -3.55 904 -20.56 0.0008
2015-05-14 2015-03-31 13F HALYARD HEALTH COM 40650V100 23,126 -4,523 -16.36 1,138 -9.47 0.0011
2015-02-17 2014-12-31 13F HALYARD HEALTH COM 40650V100 27,649 27,649 1,257 0.0011
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2016-02-12 2015-12-31 13F HALYARD HEALTH COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-11-13 2015-09-30 13F HALYARD HEALTH COM Call 1,188 0.00 34 -29.17 n/a n/a n/a
2015-08-13 2015-06-30 13F HALYARD HEALTH COM Call 1,188 -11.61 48 -27.27 n/a n/a n/a
2015-05-14 2015-03-31 13F HALYARD HEALTH COM Call 1,344 -86.79 66 -85.75 n/a n/a n/a
2015-02-17 2014-12-31 13F HALYARD HEALTH COM Call 10,176 463 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2016-02-12 2015-12-31 13F HALYARD HEALTH COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-11-13 2015-09-30 13F HALYARD HEALTH COM Put 6,792 -10.16 193 -36.93 n/a n/a n/a
2015-08-13 2015-06-30 13F HALYARD HEALTH COM Put 7,560 -23.17 306 -36.78 n/a n/a n/a
2015-05-14 2015-03-31 13F HALYARD HEALTH COM Put 9,840 -55.09 484 -51.41 n/a n/a n/a
2015-02-17 2014-12-31 13F HALYARD HEALTH COM Put 21,912 996 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.